Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abstract, Academy, affiliate, ambition, ARO, ARR, Atlanta, ATM, BCV, bioengineered, BKV, BKVAN, BKVHC, BL, Bristol, BTD, Bulletin, Cadillac, capitalizable, CAR, carryforward, catalyze, cognitive, compatible, Congressional, contrast, Cowen, cyclophosphamide, decade, demyelinating, demyelination, deregulation, disgorgement, easier, Empliciti, entry, evolution, excise, extracted, Fate, flare, flat, foot, forthcoming, fourteen, frailty, France, fumarate, gap, Georgia, Germany, Gilead, ground, HPV, indefinite, indefinitely, inhaled, instilled, interval, Italy, IV, JC, JCV, Juno, KEYTRUDA, Kingdom, land, layer, leukoencephalopathy, lifelong, lymphodepleting, marginal, MatchMe, metric, mobilized, Moderna, modest, monomethyl, MRI, MSD, MSKCC, multifocal, myelin, myelination, nephropathy, Notwithstanding, null, ocrelizumab, offshore, oncologist, optic, ORR, owner, ozamimod, pathophysiology, PCAOB, pembrolizumab, plasmablastic, PML, PMS, poised, portal, pretreatment, prodrug, proposition, proteasome, ProTmune, Pte, quiescence, radiation, radiologist, Regenerative, remeasurement, repatriated, retirement, RMAT, SAB, score, scrutiny, sequelae, seronegative, solution, Spain, sparing, spinal, Squibb, steady, Switzerland, tabelecleucel, taxation, tenant, Tessa, Thalomid, travel, Turkey, Tx, underwritten, undiscounted, urge, Viracta, vitamin, widespread
Removed:
abnormal, activate, activin, acute, adult, alloreactive, altered, applying, assessed, assessing, Bioscience, breast, British, cancellation, cancelled, characterize, collective, combat, comparison, complication, compound, consultant, dark, de, detectable, diverse, efficiently, elevated, emission, encephalopathy, eradication, exchanged, fell, focused, focusing, forfeited, fusion, gastric, Haematologica, heart, image, intensity, journal, Karolinska, labeled, lacked, led, lethal, load, lung, measure, metabolic, morbidity, noted, novo, occurring, originally, ovarian, overt, pancreatic, partner, PCR, permanent, PET, polymerase, poor, positron, preemptive, proportion, prosecuted, radiographic, recapitalization, refer, reflecting, resistance, restriction, retinal, sensitive, shipping, signaling, soluble, strain, substance, substantive, sudden, suggesting, surgical, switch, symptomatic, technique, tomography, transplantation, unblinding, undistributed, vast, visible, week, weekly
Filing tables
Filing exhibits
Related press release
ATRA similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in registration statements No. 333-207876 on Form S-3 and No. 333-199508, No. 333-204076, No. 333-209961, No. 333-214431, No. 333-219763 on Form S-8 of our report dated February 27, 2018, relating to the consolidated financial statements appearing in this Annual Report on Form 10-K of Atara Biotherapeutics, Inc. for the year ended December 31, 2017.
/s/ DELOITTE & TOUCHE LLP
San Jose, California
February 27, 2018